Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 6/20 | 0.47 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.46 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | NAAA | Q02083 | 1/20 | 0.38 |
| ▸ | APP | P05067 | 2/20 | 0.38 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.36 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.36 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28290892 | 1.00 | ACHE (0.47) | ACHEGPR84FFAR1FFAR4ALDH1A1 | |
| SCHEMBL8617758 | 1.00 | ACHE (0.47) | ACHEGPR84FFAR1FFAR4ALDH1A1 | |
| SCHEMBL27575500 | 1.00 | ACHE (0.47) | ACHEGPR84FFAR1FFAR4ALDH1A1 | |
| SCHEMBL8621718 | 1.00 | ACHE (0.47) | ACHEGPR84FFAR1FFAR4ALDH1A1 | |
| SCHEMBL575111 | 1.00 | ACHE (0.47) | ACHEGPR84FFAR1FFAR4ALDH1A1 | |
| SCHEMBL29013659 | 1.00 | ACHE (0.47) | ACHEGPR84FFAR1FFAR4ALDH1A1 | |
| SCHEMBL628079 | 1.00 | ACHE (0.47) | ACHEGPR84FFAR1FFAR4ALDH1A1 | |
| SCHEMBL29244356 | 0.97 | ACHE (0.46) | ACHEGPR84FFAR1FFAR4ALDH1A1 | |
| Ethylene Glycol SCHEMBL7939434 | 0.97 | ACHE (0.46) | ACHEGPR84FFAR1FFAR4ALDH1A1 | |
| SCHEMBL575104 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2473261-A2 | REVERSE OSMOSIS COMPOSITE MEMBRANES FOR BORON REMOVAL | General Electric Company (US) | 2012-07-11 | — | — | EP | disclosed |
| WO-2011025607-A2 | REVERSE OSMOSIS COMPOSITE MEMBRANES FOR BORON REMOVAL | GENERAL ELECTRIC COMPANY (US) | 2011-03-03 | — | — | WO | disclosed |